Related Experiment Videos
An essential role for DNA methyltransferase DNMT3B in cancer cell survival
Normand Beaulieu1, Steves Morin, Ian C Chute
1Department of Molecular Biology, MethylGene Inc., Montreal H4S 2A1, Canada.
Abstract:
Abnormal methylation and associated silencing of tumor suppressor genes is a common feature of many types of cancers. The observation of persistent methylation in human cancer cells lacking the maintenance methyltransferase DNMT1 suggests the involvement of other DNA methyltransferases in gene silencing in cancer. To test this hypothesis, we have evaluated methylation and gene expression in cancer cells specifically depleted of DNMT3A or DNMT3B, de novo methyltransferases that are expressed in adult tissues. Here we have shown that depletion of DNMT3B, but not DNMT3A, induced apoptosis of human cancer cells but not normal cells. DNMT3B depletion reactivated methylation-silenced gene expression but did not induce global or juxtacentromeric satellite demethylation as did specific depletion of DNMT1. Furthermore, the effect of DNMT3B depletion was rescued by exogenous expression of either of the splice variants DNMT3B2 or DNMT3B3 but not DNMT1. These results indicate that DNMT3B has significant site selectivity that is distinct from DNMT1, regulates aberrant gene silencing, and is essential for cancer cell survival.
Insights
DNA methyltransferase DNMT3B is essential for cancer cell survival, regulating gene silencing and promoting apoptosis in cancer cells but not normal cells.
Area of Science:
- * Molecular biology
- * Cancer research
- * Epigenetics
Background:
- * Aberrant DNA methylation and tumor suppressor gene silencing are hallmarks of cancer.
- * The role of de novo DNA methyltransferases (DNMTs) in cancer-specific gene silencing is not fully understood.
- * DNMT1, a maintenance methyltransferase, is crucial for DNA methylation, but other DNMTs may contribute to cancer epigenetics.
Purpose of the Study:
- * To investigate the role of de novo DNA methyltransferases DNMT3A and DNMT3B in cancer cell survival and gene silencing.
- * To determine if DNMT3A or DNMT3B depletion affects cancer cell viability and gene expression.
- * To compare the site selectivity and function of DNMT3B with DNMT1 in cancer cells.
Main Methods:
- * Depletion of DNMT3A or DNMT3B in human cancer cell lines using specific depletion strategies.
- * Analysis of global and specific gene methylation patterns and gene expression levels.
- * Assessment of apoptosis induction and cell viability upon DNMT depletion.
- * Rescue experiments using exogenous expression of DNMT splice variants.
Main Results:
- * Depletion of DNMT3B, but not DNMT3A, induced apoptosis in cancer cells while sparing normal cells.
- * DNMT3B depletion reactivated expression of methylation-silenced genes.
- * DNMT3B depletion did not cause global or juxtacentromeric satellite demethylation, unlike DNMT1 depletion.
- * The pro-apoptotic and gene-reactivating effects of DNMT3B depletion were rescued by DNMT3B splice variants but not DNMT1.
Conclusions:
- * DNMT3B plays a critical role in maintaining cancer cell survival through site-specific regulation of aberrant gene silencing.
- * DNMT3B's function in cancer is distinct from DNMT1, highlighting its potential as a therapeutic target.
- * Targeting DNMT3B may offer a selective approach to induce cancer cell death without harming normal cells.